HR 5122 · 114th Congress · Health

To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Introduced 2016-04-29· Sponsored by Rep. Bucshon, Larry [R-IN-8]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2016-05-12)

Plain Language Summary

[AI summary unavailable — showing source text] This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).…

Summarized by Claude AI · Non-partisan · For informational purposes only

CBO Cost Estimate

Congressional Budget Office

H.R. 5122, a bill to prohibit further action on the proposed rule regarding testing of Medicare Part B prescription drug models

Oct 4, 2016

As introduced on April 29, 2016

Full CBO report ↗

Official non-partisan budget analysis by the Congressional Budget Office

Cosponsors (20)

2 Democrats18 Republicans